Longer follow-up on Sangamo and Pfizer's gene therapy show treated patients continue to remain free of bleeds, but results for one patient could spark new questions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,